FMF Clinical Trial
Official title:
Measurement of Colchicine Levels in the Serum of FMF Patients
in this study the investigators will measure the colchicine trough levels in 80 FMF patients taking stable doses of colchicine
80 FMF patients will enroll: 20 taking 1 mg colchicine a day 20 taking 1.5 mg colchicine a day 20 taking 2 mg colchicine a day 20 taking 2.5 mg colchicine a day one blood sample for trough colchicine levels will be taken. response to treatment, colchicine side effects and anthropometric data will be collected. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05190991 -
Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
|
Phase 2 | |
Not yet recruiting |
NCT06336733 -
Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy
|
Phase 3 | |
Not yet recruiting |
NCT05292768 -
Are Mast Cells Involved in Autoinflammatory Diseases
|
||
Enrolling by invitation |
NCT04402255 -
Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever.
|
N/A | |
Completed |
NCT02466217 -
Phenomics in Autoimmune and Inflammatory Diseases
|
||
Recruiting |
NCT05980780 -
The Effect of Video Game on Children With Familial Mediterranean Fever
|
N/A | |
Completed |
NCT05398536 -
Kinesiophobia in Familial Mediterranean Fever
|
||
Not yet recruiting |
NCT06047938 -
FMF and Atheroscelerosis
|
||
Recruiting |
NCT05092776 -
Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
|
Phase 2 | |
Enrolling by invitation |
NCT04403438 -
Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic
|